These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
81 related items for PubMed ID: 6173923
1. Surface markers of fibrinogen and its physiologic derivatives revealed by antibody probes. Plow EF, Edgington TS. Semin Thromb Hemost; 1982 Jan; 8(1):36-56. PubMed ID: 6173923 [No Abstract] [Full Text] [Related]
5. Fibrinogen-fibrin: preparation and use of monoclonal antibodies as diagnostics. Kudryk BJ, Bini A, Rosebrough SF, Schaible TF. Biotechnology; 1991 Jan; 19():281-313. PubMed ID: 1723912 [No Abstract] [Full Text] [Related]
6. An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH. Plow EF, Edgington TS. J Clin Invest; 1975 Jul; 56(1):30-8. PubMed ID: 237938 [Abstract] [Full Text] [Related]
7. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products. Suzuki A, Ebinuma H, Matsuo M, Miyazaki O, Yago H. Thromb Res; 2007 Jul; 121(3):377-85. PubMed ID: 17561232 [Abstract] [Full Text] [Related]
10. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products]. Dyr JE, Cajthamlová H, Suttnar J. Cas Lek Cesk; 1990 Oct 26; 129(43):1349-51. PubMed ID: 2249231 [Abstract] [Full Text] [Related]
12. Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro. Gramse M, Bingenheimer C, Schmidt W, Egbring R, Havemann K. J Clin Invest; 1978 Apr 26; 61(4):1027-33. PubMed ID: 77863 [Abstract] [Full Text] [Related]
13. Degradation of human fibrinogen by chymotrypsin-like neutral protease from human granulocytes. Gramse M, Bingenheimer C, Havemann K. Thromb Res; 1978 Apr 26; 19(1-2):201-9. PubMed ID: 6160637 [No Abstract] [Full Text] [Related]
14. Fibrinogen/fibrin in atherogenesis. Smith EB, Thompson WD, Crosbie L, Stirk CM. Eur J Epidemiol; 1992 May 26; 8 Suppl 1():83-7. PubMed ID: 1387095 [Abstract] [Full Text] [Related]
15. Lymphocyte suppressive peptides from fibrinogen are derived predominantly from the A alpha chain. Plow EF, Edgington TS. J Immunol; 1986 Sep 15; 137(6):1910-5. PubMed ID: 2943807 [Abstract] [Full Text] [Related]
16. Immunoreactivities of fibrin(ogen) related antigens and antibodies in radioimmunoassay and latex photometric immunoassay. Sudo T, Sawai M. Nihon Ketsueki Gakkai Zasshi; 1981 Feb 15; 44(1):131-45. PubMed ID: 7315137 [No Abstract] [Full Text] [Related]
17. On the origin of urinary fibrin-fibrinogen-related antigen in glomerulonephritis. Bone JM, Sherman LA, Valdes AJ, Lubowitz H. J Lab Clin Med; 1977 May 15; 89(5):1043-52. PubMed ID: 558266 [Abstract] [Full Text] [Related]
18. Availability of the B beta(15-21) epitope on cross-linked human fibrin and its plasmic degradation products. Chen F, Haber E, Matsueda GR. Thromb Haemost; 1992 Mar 02; 67(3):335-40. PubMed ID: 1379385 [Abstract] [Full Text] [Related]